# Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

> **NCT00003386** · PHASE2 · TERMINATED · sponsor: **Gynecologic Oncology Group**

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** BCG vaccine
- **BIOLOGICAL:** autologous tumor cell vaccine
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** paclitaxel
- **OTHER:** dinitrophenyl
- **PROCEDURE:** surgical procedure

## Key facts

- **NCT ID:** NCT00003386
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-07
- **Primary completion:** 2001-04
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003386, "Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*